维度 | 组别 | 例数 | 干预前 | 干预后 |
生理功能(PF) | 对照组 | 267 | 62.62 ± 7.43 | 63.36 ± 6.97 |
| 试验组 | 307 | 63.05 ± 9.58 | 65.70 ± 8.74 |
| Z/P |
| −0.549/0.583 | −4.111/0.000 |
生理职能(RP) | 对照组 | 267 | 62.45 ± 19.19 | 65.79 ± 19.66 |
| 试验组 | 307 | 62.95 ± 19.73 | 69.32 ± 18.58 |
| Z/P |
| −0.424/0.671 | −2.490/0.013 |
躯体疼痛(BP) | 对照组 | 267 | 59.97 ± 19.59 | 61.71 ± 19.17 |
| 试验组 | 307 | 60.23 ± 18.64 | 63.11 ± 118.60 |
| Z/P |
| −0.174/0.862 | −1.196/0.232 |
总体健康(GH) | 对照组 | 267 | 59.39 ± 14.95 | 59.33 ± 13.85 |
| 试验组 | 307 | 58.31 ± 15.81 | 63.75 ± 13.65 |
| Z/P |
| −1.097/0.273 | −3.900/0.000 |
精力(VT) | 对照组 | 267 | 66.72 ± 10.36 | 67.71 ± 8.52 |
| 试验组 | 307 | 67.65 ± 8.89 | 71.24 ± 7.70 |
| Z/P |
| −0.823/0.410 | −5.238/0.000 |
社会功能(SF) | 对照组 | 267 | 89.84 ± 10.71 | 90.85 ± 9.12 |
| 试验组 | 307 | 88.46 ± 11.49 | 92.18 ± 9.59 |
| Z/P |
| −1.429/0.153 | −2.214/0.027 |